Published in Undersea Hyperb Med on June 01, 1995
Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine. J Ultrasound Med (2000) 1.23
Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine. J Ultrasound Med (2000) 0.86
Detection of microemboli by transcranial Doppler ultrasound. Tex Heart Inst J (1996) 0.83
Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine. J Ultrasound Med (2000) 0.82
General practice research. Br J Gen Pract (1996) 0.75
Section 8--clinical relevance. American Institute of Ultrasound in Medicine. J Ultrasound Med (2000) 0.75
White-coat hypertension as a cause of cardiovascular dysfunction. Lancet (1996) 4.68
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ (1997) 3.88
Anticardiolipin antibodies in an unselected stroke population. Lancet (1994) 3.66
Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology (2000) 3.64
Influence of cholesterol on survival after stroke: retrospective study. BMJ (1997) 3.64
Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet (1994) 3.03
Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology (2005) 2.69
Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet (2004) 2.51
Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke (2001) 2.26
Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology (2011) 2.24
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
Hyperinsulinism and cerebral microangiopathy. Stroke (1996) 2.03
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem (2000) 1.92
Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke (1998) 1.87
Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke (1996) 1.83
Cerebral vasoconstriction in vasovagal syncope: any link with symptoms? A transcranial Doppler study. Circulation (2001) 1.72
Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry (2005) 1.58
Gender differences in spontaneous cervical artery dissection. Neurology (2006) 1.52
Medical problems of sport diving. Br Med J (Clin Res Ed) (1985) 1.51
Impaired hemodynamics and neural activation? A fMRI study of major cerebral artery stenosis. Neurology (2003) 1.48
Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Stroke (2000) 1.47
Differentiation between intracerebral hemorrhage and ischemic stroke by transcranial color-coded duplex-sonography. Stroke (1998) 1.45
Functional outcome measures in contemporary stroke trials. Int J Stroke (2009) 1.43
C-reactive protein and outcome after ischemic stroke. Stroke (1999) 1.42
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord (2000) 1.40
Effect of a gonadotropin releasing hormone analog on cerebral hemodynamics in premenopausal women. Climacteric (2005) 1.38
Phase IIa randomized double-blind, placebo-controlled study of inhaled apomorphine as acute challenge for rescuing 'off' periods in patients with established Parkinson's disease. Eur J Neurol (2013) 1.38
Clinical relevance of intracranial microembolic signals in patients with left ventricular assist devices. A prospective study. Stroke (1996) 1.37
Clinical experience with excitatory amino acid antagonist drugs. Stroke (1995) 1.33
Rapid virological surveillance of community influenza infection in general practice. BMJ (2000) 1.31
Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis. Antimicrob Agents Chemother (1999) 1.30
Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM (2000) 1.27
Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs. Biochimie (2005) 1.26
Mechanism of ischemic infarct in spontaneous carotid dissection. Stroke (2004) 1.25
Problematic gambling on dopamine agonists: Not such a rarity. Mov Disord (2006) 1.20
Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group. J Infect (1999) 1.18
A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis (2006) 1.15
Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke (1999) 1.12
Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry (2003) 1.11
Anticoagulation monitoring with transcranial Doppler. Lancet (1994) 1.11
Viral spectrum of an established chimpanzee liver cell line. Proc Soc Exp Biol Med (1966) 1.10
Neuroprotection for acute stroke: making clinical trials work. Stroke (1999) 1.07
The experiences of an acute stroke unit--implications for multicentre acute stroke trials. J Neurol Neurosurg Psychiatry (1993) 1.06
Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes. Eur J Clin Pharmacol (1986) 1.05
Chromosome aberrations in divers. Undersea Biomed Res (1984) 1.04
Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. J Mol Endocrinol (1996) 1.03
Peroneal stimulator; evaluation for the correction of spastic drop foot in hemiplegia. Arch Phys Med Rehabil (1996) 1.03
The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease. Stroke (1998) 1.03
The prognostic value of the components of the Glasgow Coma Scale following acute stroke. QJM (2003) 1.03
Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study. J Med Chem (1999) 1.03
Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man. Br J Clin Pharmacol (1987) 1.02
Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke. Neurology (2004) 1.01
Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Neurol Scand (2003) 1.00
Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke (1998) 1.00
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J (1991) 1.00
Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Lancet (1997) 0.99
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry (2009) 0.99
A recognition tool for transient ischaemic attack. QJM (2008) 0.99
Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke (1997) 0.98
Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. Eur J Neurol (2005) 0.97
The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients. Eur J Clin Pharmacol (1987) 0.97
Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjects. J Cardiovasc Pharmacol (1987) 0.97
Differentiation between gaseous and formed embolic materials in vivo. Application in prosthetic heart valve patients. Stroke (1994) 0.97
Stroke in pregnancy and the puerperium: what magnitude of risk? J Neurol Neurosurg Psychiatry (1995) 0.96
Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry (2004) 0.96
Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment. Clin Pharmacol Ther (1987) 0.95
Excitatory amino acid antagonists for acute stroke. Cochrane Database Syst Rev (2003) 0.94
The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovasc Dis (2005) 0.93
Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure. Br Heart J (1993) 0.93
Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs. Br J Clin Pharmacol (1991) 0.93
A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Stroke (1995) 0.92
Transhemispheric passage of microemboli in patients with unilateral internal carotid artery occlusion. Stroke (1993) 0.92
Phosphinic peptides as zinc metalloproteinase inhibitors. Cell Mol Life Sci (2004) 0.91
Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review. Acta Neurol Scand (2014) 0.91
Duration of neuroprotective treatment for ischemic stroke. Stroke (1998) 0.91
Perindopril. A review of its pharmacokinetics and clinical pharmacology. Drugs (1990) 0.91
Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma. Am J Med (1988) 0.90
Susceptibility to cerebral infarction in the stroke-prone spontaneously hypertensive rat is inherited as a dominant trait. Stroke (1998) 0.90
Carotid dissection with permanent and transient occlusion or severe stenosis: Long-term outcome. Neurology (2003) 0.89
Streptokinase in acute ischemic stroke: an individual patient data meta-analysis : The Thrombolysis in Acute Stroke Pooling Project. Stroke (2000) 0.88
ABC of arterial and venous disease. Acute stroke. BMJ (2000) 0.88
Prevention of shoulder subluxation after stroke with electrical stimulation. Stroke (1999) 0.88
Seasonal variability in spontaneous cervical artery dissection. J Neurol Neurosurg Psychiatry (2006) 0.88
Epidemiological aspects of referral to TIA clinics in Glasgow. Scott Med J (2007) 0.87
Transcranial Doppler detection of microemboli in prosthetic heart valve patients: dependency upon valve type. Eur J Cardiothorac Surg (1996) 0.87
Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens (1995) 0.86
Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes. Diabet Med (2006) 0.86
Angiotensin-converting enzyme inhibitors in the elderly. Am Heart J (1989) 0.86
Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK. Cerebrovasc Dis (2005) 0.86
Melioidosis in imported non-human primates. J Wildl Dis (1970) 0.85
Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke (2001) 0.85